Stock Rich List
Nasdaq: BRVE

Braveheart Bio insiders

The officers, directors and 10% owners of Braveheart Bio, Inc. who hold the most stock, valued at the live BRVE price.

$19.27
BRVE today +$740K (+3.99%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
8
Their BRVE stock
$754M
Market value
$1.58B
Held by ranked insiders
47.7%

Insiders by value of BRVE holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Forbion Growth Opportunities Fund III Cooperatief U.A.10% owner21,826,024$421M26.6%Corporate
2Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% owner7,420,091$143M9.04%Corporate
3Travis MurdochCEO and President7,306,241$141M8.90%1160th
4David I. MalekDirector773,571$14.9M0.94%6476th
5Christopher ViehbacherDirector759,857$14.6M0.93%4810th
6James Paul RickeyChief Financial Officer612,251$11.8M0.75%7757th
7Michele A. AndersonChief Development Officer332,161$6.4M0.40%12189th
8Jason Coloma V.Director93,607$1.8M0.11%5362nd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Braveheart Bio; see each profile for the filing.